Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19.
Ye LiuRan LuJunhong WangQin ChengRuitao ZhangShuisheng ZhangYunyi LeHaining WangWenhua XiaoHongwei GaoLin ZengTianpei HongPublished in: BMC endocrine disorders (2021)
The prevalence of undiagnosed pre-existing diabetes among patients with COVID-19 is high in China. Diabetes, even newly defined by HbA1c testing at admission, is associated with increased mortality in patients with COVID-19. Screening for undiagnosed diabetes by HbA1c measurement should be considered in adult Chinese inpatients with COVID-19.